Shares of Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 363,192 shares.
Evofem Biosciences Trading Up 3.3 %
The stock has a 50 day moving average of $0.01 and a 200-day moving average of $0.01.
About Evofem Biosciences
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Stories
- Five stocks we like better than Evofem Biosciences
- High Flyers: 3 Natural Gas Stocks for March 2022
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Why Invest in 5G? How to Invest in 5G Stocks
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
